Although the free energy perturbation approach is a rigorous method for estimating the relative binding free energy between an enzyme and its inhibitors, it is computationally expensive. This paper examines the accuracy at different levels of approximations, following the series expansion of free energy derived by Åqvist et al. Level-0 calculates only the enzyme-inhibitor interaction energy at the minimum energy configuration without solvent. In Level-0MD, the inhibitor configurations are sampled by molecular dynamics. These levels assume that the second-and higher order terms in the series expansion can be neglected and that the interaction energies in the bound and unbound states are equal. Level-1 does not assume equal interaction energies in the bound and unbound states. Level-1S includes the solvent contribution but both enzyme and inhibitor are fixed. In Level-1SMD, the inhibitor configurations are sampled by molecular dynamics. Level-2SMD retains the second-order term. We chose seven HIV-1 protease inhibitors for study: A77003, A76889, A76928, A78791, A74704, JG365 and MVT101. Level-0 and Level-0MD were found to give essentially the same relative interaction energies by using the AMBER force field, suggesting that fixing atomic positions may be a good approximation in some cases. However, as expected, Level-0 or Level-0MD gave poor predictions for the relative binding free energies between hydrophobic inhibitors (e.g. A77003) and more hydrophilic inhibitors (e.g. JG365). Level-1SMD produced a much better correlation between calculated and experimental results. Inclusion of the second-order term did not improve the accuracy.
Introduction
The prediction of binding free energy is an important step in rational or structure-based drug design (Caflisch and Karplus, 1995; Rosenfeld et al., 1995) . It has been used in the design of human immunodeficiency virus (HIV) protease inhibitors (Holloway et al., 1995) , which are potential drugs for treating the acquired immunodeficiency syndrome (AIDS) (Cohen, 1996) . To obtain the binding free energy, several different methods have been proposed (Straatsma and McCammon, 1992; Åqvist et al., 1994; Holloway et al., 1995; Verkhivker et al., 1995) . Among them, the free energy perturbation method (Straatsma and McCammon, 1992) is the most rigorous one, but is computationally very expensive (Ferguson et al., 1991; Rao et al., 1992; Reddy et al., 1994; Rao and Murcko, 1996) . The simplest method (Holloway et al., 1995) calculates only the enzyme-inhibitor interaction energy at the minimum energy configuration, without including the solvation water molecules. This method is very fast, but could be oversimplified if the desolvation energy and entropic contributions are important. By using empirical approaches, Verkhivker et al. (1995) found substantial differences in desolvation energy and entropy among the seven inhibitors they studied. Åqvist et al. (1994) derived an equation for the series expansion of the free energy difference. In this form, the original ensemble average for the exponential of potential energies reduces to the ensemble average of simple potential energies. Since the exponential dramatically amplifies the fluctuation of potential energies, the ensemble average of simple potential energies is expected to converge much faster. However, the series expansion involves an infinite number of terms. In the linear interaction energy (LIE) approximation, Åqvist and co-workers (Åqvist et al., 1994; Hansson and Åqvist, 1995) assumed that the second-and higher order terms could be neglected. Therefore, the LIE approximation can be regarded as the first-order approximation of the binding free energy.
In this paper, we report our results for the relative binding free energies calculated at different levels of approximation. Level-0, Level-0S and Level-0MD all neglect the second-and higher order terms in the series expansion, and assume that the interaction energies in the bound and unbound states are equal. Level-0 calculates only the enzyme-inhibitor interaction energy at the minimum energy configuration of the bound state without including solvent molecules. It is the same as the approximation used by Holloway et al. (1995) . Level-0S includes the desolvation energy estimated by empirical models at the minimum energy configuration. To see whether fixing atoms at the minimum energy configuration is appropriate, we also examined the Level-0MD, where the inhibitor configurations were sampled by molecular dynamics.
Level-1, Level-1S and Level-1SMD also neglected the second-and higher order terms in the series expansion, but do not assume equal interaction energies in the bound and unbound states. They are first-order approximations similar to the LIE approximation used by Åqvist and co-workers. However, in evaluating the first-order term, they decomposed the interaction energy into polar (electrostatic) and non-polar (van der Waals) parts, and then calculated the free energy difference between charged and uncharged states. Their method requires empirical coefficients, in addition to force field parameters. Our approach is to estimate directly the free energy difference between the bound and unbound states without introducing empirical coefficients other than the established force field parameters. An advantage of our approach is that the results obtained in Level-1SMD can be used to estimate the size of the secondorder term, which is important for checking the validity of the first-order approximation.
We chose for this study the seven inhibitors reported by Verkhivker et al. (1995) , not only because they have been investigated more extensively (Gustchina et al., 1994; Hosur et al., 1994; Verkhivker et al., 1995) , but also because of their variety. Five of these inhibitors, A77003, A76889, A76928, A78791 and A74704, are hydrophobic. The other two, JG365 and MVT101, are more hydrophilic. Different hydrophobicities could test the accuracy of our treatment with regard to the solvent contribution. Among the hydrophobic inhibitors, A77003, A76889 and A76928 are diastereomers, but exhibiting distinct binding modes to the HIV protease (Hosur et al., 1994) . In the bound state, the enzyme-inhibitor interaction energy for A76928 was found to be significantly stronger than that for A77003 (Verkhivker et al., 1995) , but experiments have shown that the two inhibitors have approximately the same binding free energy (Hosur et al., 1994) . According to the first-order approximation derived by Åqvist et al. (1994) , the binding free energy is given by the arithmetic average of the interaction energies in both the bound and unbound states. It would be of interest to see whether or not including the interaction energy in the unbound state could improve the calculated results.
Materials and methods

Series expansion of binding free energy
Consider a system including an enzyme, inhibitor and solvation water molecules. Let E u and E b be the potential energies of the system in the unbound and the bound states, respectively. The binding free energy can be written as
where k B is the Boltzmann constant, T is the absolute temperature and the ensemble average Ͻ Ͼ u runs over all configurations in the unbound state. The quantity to be evaluated in the ensemble average involves the exponential of the potential energy difference, E b Ϫ E u . Any fluctuation in the potential energy difference is amplified by the exponential, which makes the convergence of the ensemble average very slow. It is desirable to express the binding free energy in terms of the ensemble average of simple potential energy difference. After series expansion of the exponential and logarithm, Equation 1 may be rewritten as
where ∆E ¥ E b Ϫ E u (Åqvist et al., 1994) . Since ∆E represents the interaction energy between the enzyme and inhibitor, Ͻ∆EϾ b may be called the 'interaction energy in the bound state' and Ͻ∆EϾ u , the 'interaction energy in the unbound state'.
Level-0
If the second-and higher order terms in Equation 2 can be neglected, and the interaction energies in the bound and unbound states are equal, the equation reduces to
which will be referred to as the zeroth-order approximation. Even in this highly simplified form, evaluation of Ͻ∆EϾ b is still expensive if the solvation water molecules are included and molecular dynamics (MD) is used to sample Boltzmanndistributed configurations. During MD sampling, solvation water molecules may escape from the enzyme-inhibitor com-plex unless some kind of boundary conditions (e.g. periodic) are imposed, which would dramatically increase the computation time.
In our Level-0 approximation, the solvation water molecules are excluded and ∆G bind is assumed to be proportional to the interaction energy in the minimum energy configuration of the bound state, q b,min :
This approximation has been used by other researchers (Holloway et al., 1995; Weber and Harrison, 1996) . Let E e (q b,min ), E i (q b,min ) and E c (q b,min ) be the potential energies of the enzyme, inhibitor and enzyme-inhibitor complex in q b,min , respectively. Then,
To obtain ∆E(q b,min ), we started from the crystal structures deposited in the Protein Data Bank (Bernstein et al., 1977) . They include the HIV-1 protease complexes with A77003, A76889, A76928, A78791 (Hosur et al., 1994) , A74704 (Erickson et al., 1990) , JG365 (Swain et al., 1990) and MVT101 . In these complexes, the water molecule which makes hydrogen bonds with both the flap and inhibitor was included during the energy minimization for the bound state. However, this water molecule (referred to as W301) was excluded from the calculation of the interaction energy as defined by Equation 5. Inclusion of W301 in the interaction energy will not affect the relative binding affinities, since the interaction energy between W301 and neighboring residues is about the same for these inhibitors.
The HIV-1 protease is a homodimer, each subunit consisting of 99 residues. It has been noticed that the distance between the δ-oxygen atoms of Asp25 and Asp25Ј is in the range 2.6-3.0 Å, suggesting that the two aspartates may share a proton (Gustchina et al., 1994) . We arbitrarily assigned a proton to Asp25Ј for all enzyme-inhibitor complexes. The charge states of other residues were assigned as they should be at pH 7. Both N and C termini were uncharged. The total charges are ϩ2 for the first subunit and ϩ3 for the second subunit. The inhibitor MVT101 contains a positive charge. Other inhibitors are neutral.
All of our calculations were performed with the Insight-II/ Discover modeling package (Biosym/MSI, 1995) . The whole system was divided into four 'molecules'. Molecules 1 and 2 represent the two subunits of the protease, molecule 3 denotes the inhibitor and molecule 4 contains a single water molecule W301. With Discover, one or more molecules may be excluded from the calculation of the potential energy of the system. By excluding molecules 3 and 4, we obtain the potential energy of the enzyme, E e . By excluding molecules 1, 2 and 4, we obtain the potential energy of the inhibitor, E i . The potential energy of the enzyme-inhibitor complex, E c , can be obtained by excluding molecule 4. After E e , E i and E c have been obtained, ∆E can be calculated by Equation 5.
To obtain q b,min , the heavy atoms of the enzyme were fixed at the crystal conformation of the enzyme-inhibitor complex, while minimizing all inhibitor atoms and hydrogen atoms of the enzyme. For minimization methods, we started from steepest descents. After the convergence reached 20 kcal/ mol.Å, the minimization method was switched to conjugate gradients. The final convergence was set to be 0.001 kcal/ mol.Å.
The force fields used in our calculations were AMBER and CFF91 as implemented in the Insight-II/Discover package (Biosym/MSI, 1995) . For the non-bond energy summation, the cell-multipole method was chosen for CFF91. This method does not have a cut-off. It is much faster and more accurate than the pairwise summation with a 9.5 Å cut-off radius (Biosym/MSI, 1995) . However, for the van der Waals interactions of the AMBER force field, the cell-multipole method cannot be used in Discover. Therefore, for AMBER, we used the cell-multipole method only for the electrostatic interactions, but using the atom-based method with a 12 Å cut-off for the van der Waals interactions. The interaction energy depends strongly on the dielectric constant. There are indications that the dielectric constant ε ϭ 4r is preferred over ε ϭ r (Sansom et al., 1992) . We obtained results for three different dielectric constants, ε ϭ 1, r and 4r.
Level-0MD
Suppose Ͻ∆EϾ b is proportional to ∆E(q b,min ), then for estimating relative binding free energies at the zeroth-order approximation, MD sampling is not necessary, which could save an enormous amount of computation time. This point can be tested by actually evaluating Ͻ∆EϾ b . For simplicity, we only evaluated the ensemble average of ∆E over inhibitor configurations. The solvent was excluded and the enzyme was fixed during MD sampling. Our Level-0MD approximation assumes that
where the subscript i emphasizes that the ensemble average is over the inhibitor configurations only. In our MD simulation, the time step was chosen to be 0.001 ps. After q b,min had been obtained in the Level-0 approximation, the system was gradually heated to 300 K, which took about 1.5 ps, then the MD simulation was performed to generate a series of configurations at a constant temperature of 300 K. In these MD simulations, all atoms in the enzyme and W301 were fixed by using a command, 'atomMovability set fixed', available in Discover. An MD run for each inhibitor took 20 ps or longer. For every 20 steps, ∆E was calculated in the same way as described for Level-0. The values of ∆E were saved for analyzing their fluctuation around Ͻ∆EϾ b,i which can be used to estimate the size of the second-order term in Equation 2.
Level-0S
In our inhibitor set, some inhibitors are significantly more hydrophilic than the others. It is unlikely that the Level-0 approximation could give a good correlation with experimental results. Inclusion of the desolvation energy might improve the accuracy. The Level-0S approximation assumes that
where
Equation 8 The solvation energies given in Equation 8 were obtained by the SOLVATION module implemented in Insight-II (Biosym/MSI, 1995) . Several empirical models are available in this package. We found that the model of Vila et al. did not produce reasonable results for our system, hence it was not pursued further. The DelPhi-based model, which solves the Poisson-Boltzmann equation, is more time consuming. Our preliminary results did not encourage further investigation using this model either. Therefore, complete results were obtained by other models: Ooi et al. (1987) and Wesson and Eisenberg (1992) . These models use empirical atomic solvation scales and calculate the solvent-accessible surface area for each atom in the molecule.
Level-1
If the second-and higher order terms in Equation 2 can be neglected, Equation 2 reduces to
which will be referred to as the first-order approximation. This approximation is assumed to be more accurate than the zerothorder approximation, since it does not assume that Ͻ∆EϾ u ϭ Ͻ∆EϾ b . The LIE approximation used by Åqvist and coworkers (Åqvist et al., 1994, Hansson and Åqvist, 1995 ) is a first-order approximation. However, they decomposed the interaction energy into polar (electrostatic) and non-polar (van der Waals) parts and then calculated the free energy difference between the charged and uncharged states. Our approach is to evaluate Ͻ∆EϾ u and Ͻ∆EϾ b directly, but at different levels of sophistication. In our Level-1 approximation, the solvation water molecules are excluded and both Ͻ∆EϾ u and Ͻ∆EϾ b are assumed to be proportional to ∆E in their minimum energy configurations. That is,
where, similarly to Equation 5, (11) and q u,min represents the minimum energy configuration of the unbound state. It is given by q u,min ¥ {q e,min ,q i,min } min (12) where q e,min and q i,min are the minimum energy configurations of the separate enzyme and inhibitor, respectively. The subscript 'min' to the braces, { } min , denotes the minimum energy configuration of the whole complex while the enzyme and inhibitor are fixed at their internal structures specified in the braces (Figure 1 ). The rationale for Equations 11 and 12 is as follows. ∆E is defined to be E b Ϫ E u . In the unbound state, E u is simply the sum of the potential energies for the separate enzyme and inhibitor [ϭ E e (q u,min ) ϩ E i (q u,min )], but E b is the potential energy of the system when the enzyme and inhibitor are 'bound', which is given by E c (q u,min ). In our approach, q e,min was obtained from the crystal structure of the native HIV-1 protease and q i,min was obtained by energy minimization of the inhibitor in vacuo, starting from its crystal structure in the complex. Typically, 1000 steps or more were used. To obtain q u,min , we first placed the inhibitor at the active site of the native HIV-1 protease, with orientation close to that in the observed protease-inhibitor complex ( Figure 1C ). This was carried out by superimposing the Cα atoms of residues Arg8, Asp25, Arg8Ј and Asp25Ј (Collins et al., 1995) between the native enzyme and the enzyme-inhibitor complex. Then, the inhibitor and enzyme were minimized separately to obtain q e,min and q i,min . Since our coordinate system actually contains both inhibitor and enzyme, the command 'atomMovability set excluded' was used in the energy minimization to exclude the enzyme when minimizing the inhibitor, or to exclude the inhibitor when minimizing the enzyme. For the enzyme, we fixed the heavy atoms in the native crystal structure , and minimized only the hydrogen atoms.
Having found q e,min and q i,min , the configuration q u,min was obtained by a Monte Carlo method to search for the minimum energy configuration of the complex, treating the enzyme and inhibitor as two rigid bodies. During the MC search, we fixed the 'coordinates' of the enzyme. That is, the atomic positions in q e,min did not change throughout the simulation. To find {q e,min , q i,min } min , the internal structure of the inhibitor was fixed at q i,min , but the whole inhibitor may translate or rotate. For each MC step, the inhibitor was translated by a random distance and rotated by a random angle around any one of three axes. After the random displacement had been performed on all three axes, the new position was either accepted or rejected according to the standard MC procedure (Metropolis et al., 1953) . Because the initial configuration was near its minimum, the MC search was very fast. We typically used 500 MC steps. In a few cases, (e.g. A76928 and MVT101), a longer MC run was performed. Discover does not provide such an MC procedure. It was implemented by ourselves, using Discover's BTCL language.
Level-1S
The Level-1S approximation assumes that 
Level-1SMD
The Level-1SMD approximation assumes that
were Ͻ∆EϾ b,i , ∆G desol (q u,min ) and ∆G desol (q b,min ) are the same as defined earlier, and Ͻ∆EϾ u,i represents the ensemble average of ∆E over inhibitor configurations in the unbound state. To estimate Ͻ∆EϾ u,i , the enzyme was fixed at q e,min , and the MD simulation was performed to generate a series of inhibitor configurations at T ϭ 300 K. In our approach, the inhibitor was first placed at the active site of the native HIV-1 protease as described earlier for obtaining q u,min . During the MD simulation for generating inhibitor configurations, the enzyme was excluded and only the inhibitor configuration q i was changing in vacuo. The initial inhibitor configuration was taken from the crystal structure of the enzyme-inhibitor complex. After every 20 MD steps, ∆E was evaluated, which requires the MC search for the configuration {q e,min , q i } min as described in Level-1. Only 50 MC steps were used to find {q e,min , q i } min , because the inhibitor configuration did not change significantly during the 20 MD steps. Our simulation protocol is summarized as follows:
(a) 20 MD steps to generate a new inhibitor configuration q i ; (b) 50 MC steps to find {q e,min , q i } min ; (c) evaluation of ∆E at {q e,min , q i } min .
Ͻ∆EϾ u,i was obtained by repeating (a) to (c). For each inhibitor, a total of 3000-7000 MD steps (equivalent to 3-7 ps) were performed. The values of ∆E were saved for analyzing their fluctuation around Ͻ∆EϾ u,i , which can be used to estimate the second-order term as given below.
Estimates of the second-order term
To see whether or not the first-order approximation is appropriate, it is important to estimate the contribution from the second-order term. Our approach can be used to obtain the second-order term arising from the thermal motion of the inhibitor. From Equation 2, this part of the second-order term is given by
During the MD simulations for the Level-0MD and Level-1SMD approximations, values of a series of ∆Es were saved. Therefore, Ͻ(∆E Ϫ Ͻ∆EϾ u,i ) 2 Ͼ u,i and Ͻ(∆E Ϫ Ͻ∆EϾ b,i ) 2 Ͼ b,i can be calculated without additional simulations. Table I shows the results for the enzyme-inhibitor interaction energy at the minimum energy configuration, q b,min , compared with the observed inhibition constant K i (nM) and the interaction energy obtained by knowledge-based mean field potentials (Verkhivker et al., 1995) . ∆E(AMBER, ε ϭ 4r) refers to the interaction energy obtained by Equation 5 using the AMBER force field with ε ϭ 4r. For ∆E(CFF91, ε ϭ 4r), the CFF91 force field with ε ϭ 4r was used. By comparing with the mean field results, we find that AMBER, ε ϭ r and ε ϭ 1 dramatically overestimate the interaction energy for A74704 and MVT101. For AMBER, the choice of ε ϭ 4r seems to be more reasonable than the other dielectric constants, consistent with the finding of Sansom et al. (1992) . However, for CFF91, ε ϭ 4r, the interaction energy for JG365 is only slightly stronger than that for A76928 and A77003. The relative interaction energies using ε ϭ 1 appear to be more consistent with mean field results. Therefore, we chose AMBER, ε ϭ 4r and CFF91, ε ϭ 1 for further investigations.
Results
Level-0
Level-0MD
In the Level-0MD approximation, the solvation water molecules were excluded and only the inhibitor configurations were sampled. Table II presents the results obtained using AMBER, ε ϭ 4r. As defined earlier, ∆G 0 ϭ ∆E(q b,min ) and ∆G 0MD ϭ Ͻ∆EϾ b,i . We note that the differences between ∆G 0 and ∆G 0MD are approximately the same for these inhibitors, only A78791 has a somewhat larger difference than the others. This result is expected for a system whose atomic motions are basically governed by harmonic oscillations. The AMBER force field uses mainly the harmonic terms. By contrast, the CFF91 force field contains many anharmonic terms. We did not obtain complete results for Ͻ∆EϾ b,i using CFF91, ε ϭ 1, but our preliminary calculations have already indicated that the differences between ∆G 0 and ∆G 0MD vary significantly among these inhibitors (data not shown).
Level-0S
The solvation energies given in Equation 8 were obtained by the SOLVATION module implemented using Insight-II. We obtained complete results for the Ooi et al. and Wesson and Eisenberg models; the latter has two sub-models: Kyte and Doolittle (1982) and Sharp et al. (1991) . These results are given in Table III , where q b,min was obtained by using AMBER, ε ϭ 4r, but CFF91, ε ϭ 1 gave essentially the same results. We see that both the Sharp et al. (Figure 2 ).
Level-1 and Level-1S
Results for solvation and desolvation energies at q u,min are given in Tables V and VI using AMBER, ε ϭ 4r and CFF91, ε ϭ 1, respectively. The desolvation energy at q u,min is generally smaller than that at q b,min . This is because the flap is more open in q u,min than in q b,min so that less hydrophilic atoms are buried in the protein complex. We also note that for most inhibitors, ∆G s i (q u,min ) Ͼ ∆G s i (q b,min ). ∆G s i (q u,min ) is the solvation energy of the inhibitor whose configuration is taken from q u,min , i.e. obtained by energy minimization of the inhibitor in vacuo, starting from its configuration in the crystal structure of the complex. ∆G s i (q b,min ) is the solvation energy of the inhibitor with configuration taken from q b,min . The above result suggests that for most inhibitors more hydrophobic atoms are exposed after energy minimization of the inhibitor in vacuo. Exceptions are A74704 using CFF91, ε ϭ 1, and MVT101 using both AMBER, ε ϭ 4r and CFF91, ε ϭ 1. Table  VII , because its main purpose is to compare the accuracies among different levels of approximations, rather than among different solvation models. At Level-0S, the binding free energy of A76928 was overestimated by using either AMBER, ε ϭ 4r or CFF91, ε ϭ 1. This result is consistent with the finding of Verkhivker et al. (1995) that, in the bound state, the enzyme-inhibitor interaction energy for A76928 is significantly stronger than that for A77003. At Level-1S, which also calculated the interaction energy in the unbound state, the relative binding energy between A76928 and A77003 has been a q b,min was obtained by using AMBER, ε ϭ 4r, but CFF91, ε ϭ 1 gave essentially the same results. Verkhivker et al. (1995) . improved. In principle, Level-1S is expected to be more accurate than Level-0S, since the former does not assume equal interaction energy in the bound and unbound states.
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Using CFF91, ε ϭ 1, ∆G 1S is indeed better than ∆G 0S . However, by using AMBER, ε ϭ 4r, the overall correlation did not show much improvement for ∆G 1S over ∆G 0S ( Figure  2) . Possible reasons will be discussed later.
Level-1SMD
Results for Level-1SMD are presented in Table VIII using AMBER, ε ϭ 4r. Their correlations with experiments are shown in Figure 3 . Compared with Level-1S, Level-1SMD has significantly improved. In Table II , we have seen that in the bound state, Ͻ∆EϾ b,i is roughly proportional to ∆E(q b,min ). However, as shown in Table VIII , the relative values of Ͻ∆EϾ u,i are different from those of ∆E(q u,min ). This is because the free inhibitor has several local minima, giving rise to different values of ∆E(q u,min ). The energy minimization starting from a given configuration happens to reach one of these local minima. This could be the major reason why Level-1S may not be better than Level-0S. The ensemble average of many configurations is expected to be more accurate, as demonstrated by the Level-1SMD approximation. 
Estimates of the second-order term
Discussion
We have obtained relative binding free energies using a few levels of approximations for seven HIV-1 protease inhibitors with different desolvation energies. The simplest one, Level-0, calculates only the enzyme-inhibitor interaction energy at the minimum energy configuration of the bound state without including the solvation water molecules. This level produced poor results, as shown in Figure 2 . Level-0S and Level-1S take the solvent effects into account, but the water molecules were not included explicitly. Instead, it was approximated by solvation energy models (e.g. Sharp et al. and Kyte and Doolittle models) using empirical atomic solvation scales and calculating the solvent-accessible surface area for each atom in the molecule. The solvent contribution was added arithmetically to the enzyme-inhibitor interaction energy (or its ensemble averages) calculated without solvent (see Equations 7 and 13). Hence our calculated free energy is a hybridized term of the interaction energy without explicit solvent molecules and the solvent contribution obtained by empirical parameters. In Table I , we see that the magnitude of the interaction energy depends strongly on dielectric constants. Therefore, when added to the empirical solvent contribution, some of them would be either overestimated or underestimated. In this regard, it is very interesting to note that the magnitudes of the interaction energies obtained by AMBER, ε ϭ 4r are comparable to the results of Verkhivker et al. (1995) using knowledge-based interaction potentials (Table I) . Hence AMBER, ε ϭ 4r seems to be a better choice than others when this hybridized approach is used. Of course, the success of AMBER, ε ϭ 4r here may simply be coincidental. There is no theoretical justification that ε ϭ 4r should be the right choice. The only rationale for the 'distance-dependent' dielectric constant is that charge shielding for two interacting atoms by the medium (including protein, solvent and others) usually increases with increasing distance between the two atoms. Although ε ϭ 4r has been found to produce better results than ε ϭ r for some systems (Sansom et al., 1992) , further investigations are required before reaching a general conclusion.
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The results of Level-0S and Level-1S are significantly better than those of Level-0 (Figure 2) . However, Level-1S is not more accurate than Level-0S even though it is a higher order approximation. This could be due to the existence of several local minima for the free inhibitor. Level-1SMD attempted to obtain better results than Level-0S by sampling inhibitor configurations in vacuo. The results are indeed improved (Figure 3 ), but its error could still be as large as 2.5 kcal/mol (for JG365). The major source of this error may not be due to the truncation of the second-and higher-order terms in Equation 2, since inclusion of the second-order term does not improve the accuracy (Table VIII) . The error is more likely due to the following simplifications at Level-1SMD:
(a) solvent molecules were not included explicitly; (b) enzyme atoms were fixed; (c) inhibitor configurations were sampled in vacuo, not in solution; (d) the solvent contribution was calculated only at a single configuration.
As shown in Table II , the relative values of ∆E(q b,min ) are near those of Ͻ∆EϾ b,i . This suggests that in the bound state the atomic motions are likely to be governed by harmonic oscillations. Therefore, for the MD sampling in the bound state, allowing the enzyme atoms to move, or even including solvation water molecules explicitly, may not have significant improvement. However, improvement could be obtained if enzyme atoms were movable during the MD sampling in the unbound state, but this would increase the computation time enormously. The flap of the unbound HIV protease is flexible (Collins et al., 1995) ; it is beyond current computer capability to sample all possible configurations of the unbound state. In this study, the unbound protein was fixed at the crystal structure of the native HIV-1 protease ( Figure 1B ), which may not be the true minimum energy conformation of a single protein.
The crystal packing of many proteins is likely to influence the conformation, especially at the flexible flap. In the crystal structure of the native HIV-2 protease (Wilderspin and Sugrue, 1994) , its flap conformation was found to be as closed as in the inhibitor-bound structure. Obviously, if the unbound enzyme were fixed at this closed conformation, no reasonable result could be obtained, since the free inhibitor after perturbation by either energy minimization or molecular dynamics would not be able to fit into the active site when we tried to obtain q u,min . Therefore, for flexible enzymes such as HIV protease, there is some uncertainty about the best choice of the unbound conformation. Fixing the enzyme at a more open conformation than the crystal structure of the native HIV-1 protease will reduce the sensitivity of the interaction energy to inhibitor configurations. Whether this may or may not improve the accuracy of the Level-1S or Level-1SMD approximation remains to be investigated. In summary, our approach to estimating the relative binding free energies is different from that of Åqvist et al. (1994) , although we use the series expansion derived by them. Their method requires coefficients in addition to force field parameters. Our approach does not introduce any additional coefficient. The force fields and solvation energy models employed in our method have been widely used, and even implemented in commercial packages. However, to obtain a good result, we do need to choose the right dielectric constant. For the AMBER force field, ε ϭ 4r seems to be the best choice, at least for this system. In addition, for proteins whose unbound conformation is flexible, such as HIV protease, there is uncertainty about the true minimum energy conformation of the unbound state. Despite this difficulty, moderate accuracy should still be obtained.
